Pharmagen Stock Alpha and Beta Analysis

This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Pharmagen. It also helps investors analyze the systematic and unsystematic risks associated with investing in Pharmagen over a specified time horizon. Remember, high Pharmagen's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Pharmagen's market risk premium analysis include:
Beta
0.0
Alpha
0.0
Risk
13.13
Sharpe Ratio
(0.13)
Expected Return
(1.72)
Please note that although Pharmagen alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Pharmagen did 0.00  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Pharmagen stock's relative risk over its benchmark. Pharmagen has a beta of 0.00  . The returns on DOW JONES INDUSTRIAL and Pharmagen are completely uncorrelated. Book Value Per Share is likely to drop to -0.02 in 2025. Net Current Asset Value is likely to drop to -7,550 in 2025.
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Pharmagen Backtesting, Pharmagen Valuation, Pharmagen Correlation, Pharmagen Hype Analysis, Pharmagen Volatility, Pharmagen History and analyze Pharmagen Performance.
For more information on how to buy Pharmagen Stock please use our How to Invest in Pharmagen guide.

Pharmagen Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Pharmagen market risk premium is the additional return an investor will receive from holding Pharmagen long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Pharmagen. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Pharmagen's performance over market.
α0.00   β0.00

Pharmagen expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Pharmagen's Buy-and-hold return. Our buy-and-hold chart shows how Pharmagen performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Pharmagen Market Price Analysis

Market price analysis indicators help investors to evaluate how Pharmagen stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Pharmagen shares will generate the highest return on investment. By understating and applying Pharmagen stock market price indicators, traders can identify Pharmagen position entry and exit signals to maximize returns.

Pharmagen Return and Market Media

The median price of Pharmagen for the period between Thu, Nov 28, 2024 and Wed, Feb 26, 2025 is 1.0E-4 with a coefficient of variation of 66.44. The daily time series for the period is distributed with a sample standard deviation of 0.0, arithmetic mean of 0.0, and mean deviation of 0.0. The Stock received some media coverage during the period.
 Price Growth (%)  
       Timeline  
1
Exosome Research Products Industry Research Report 2023-2030, Featuring AMS, Bio-Techne, Lonza, Miltenyi Biotech, Nanosomix, Norgen Biotek, NX Pharmagen, Qiagen...
12/03/2024

About Pharmagen Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Pharmagen or other stocks. Alpha measures the amount that position in Pharmagen has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2010 2024 2025 (projected)
Inventory Turnover12.9111.6210.33
ROIC0.790.710.63
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Pharmagen in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Pharmagen's short interest history, or implied volatility extrapolated from Pharmagen options trading.

Build Portfolio with Pharmagen

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Tools for Pharmagen Stock Analysis

When running Pharmagen's price analysis, check to measure Pharmagen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharmagen is operating at the current time. Most of Pharmagen's value examination focuses on studying past and present price action to predict the probability of Pharmagen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharmagen's price. Additionally, you may evaluate how the addition of Pharmagen to your portfolios can decrease your overall portfolio volatility.